Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000242507, or "Pseudogene similar to sialyltransferase proteins," is classified as a **pseudogene**, meaning it is a genomic DNA sequence similar to a known gene but is non-functional due to mutations, deletions, or truncations. Sialyltransferases are a family of enzymes (glycosyltransferases) that catalyze the transfer of sialic acid to glycoconjugates, but as a pseudogene, ENSG00000242507 is not expected to encode a functional enzyme or protein and does not play a known active biological or disease role. It is retained in the genome as an inactive relic, and there are no known drugs, disease associations, or biomarker uses for this sequence[1][2][3][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudogene similar to sialyltransferase proteins.